News

Public Broadcasting Service (PBS)5h
FDA approves Novavax COVID-19 vaccine, but with unusual restrictions on its use
In its Friday approval letter, the FDA didn’t explain the restrictions although they reflect skepticism about ...
F.D.A. Approves Novavax Covid Vaccine With Stricter New Conditions
The agency narrowed who can get the shot and added new study requirements that could cost the company tens of millions.
After delay, FDA approves Novavax’s Covid-19 vaccine, but only for older people and those at high risk
After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter ...
FDA approves Novavax COVID vaccine with new conditions
The U.S. Food and Drug Administration on Friday approved Novavax's COVID-19 vaccine, but placed additional conditions on ...
RFK Jr.’s FDA Severely Restricts COVID Vaccine Use
The vaccine will only be available to those at high risk from Covid—excluding those who may need it to protect a relative or ...
pharmaphorum20h
UK cues up more Pfizer/BioNTech vaccines as price row looms
The UK government has started ordering COVID-19 vaccines for a 2022 booster campaign, including a 32 million-dose order for the Pfizer/BioNTech shot, even before third doses for 2021 have been ...
pharmaphorum20h
Is pharma market on the rebound in 2023?
The most obvious being those companies that had the highest selling vaccines, Pfizer and BioNtech ... again be linked to a decline in sales from COVID-19 treatments and other services.